Acumen Stock Market Value

ABOS
 Stock
  

USD 5.72  0.39  7.32%   

Acumen Pharmaceuticals' market value is the price at which a share of Acumen Pharmaceuticals stock trades on a public exchange. It measures the collective expectations of Acumen Pharmaceuticals investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Acumen Pharmaceuticals and determine expected loss or profit from investing in Acumen Pharmaceuticals over a given investment horizon. Please continue to Acumen Pharmaceuticals Correlation, Acumen Pharmaceuticals Volatility and Acumen Pharmaceuticals Alpha and Beta module to complement your research on Acumen Pharmaceuticals.
Symbol


Is Acumen Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
234.1 M
Return On Assets
(0.11) 
Return On Equity
(0.18) 
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acumen Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Acumen Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acumen Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acumen Pharmaceuticals.
0.00
11/09/2022
No Change 0.00  0.0 
In 30 days
12/09/2022
0.00
If you would invest  0.00  in Acumen Pharmaceuticals on November 9, 2022 and sell it all today you would earn a total of 0.00 from holding Acumen Pharmaceuticals or generate 0.0% return on investment in Acumen Pharmaceuticals over 30 days. Acumen Pharmaceuticals is related to or competes with News, Vivendi SA, Bollor SE, Liberty Media, Universal Music, and MultiChoice. Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treat... More

Acumen Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acumen Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acumen Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Acumen Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Acumen Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acumen Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Acumen Pharmaceuticals historical prices to predict the future Acumen Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Acumen Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Acumen Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.285.6719.55
Details
Intrinsic
Valuation
LowReal ValueHigh
0.5010.0723.95
Details
Naive
Forecast
LowNext ValueHigh
0.083.8917.77
Details
3 Analysts
Consensus
LowTarget PriceHigh
16.0023.3327.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Acumen Pharmaceuticals. Your research has to be compared to or analyzed against Acumen Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Acumen Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Acumen Pharmaceuticals.

Acumen Pharmaceuticals Backtested Returns

Acumen Pharmaceuticals appears to be risky, given 3 months investment horizon. Acumen Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.035, which signifies that the company had 0.035% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Acumen Pharmaceuticals, which you can use to evaluate the future volatility of the firm. Please makes use of Acumen Pharmaceuticals' Downside Deviation of 5.09, risk adjusted performance of 0.0525, and Mean Deviation of 5.33 to double-check if our risk estimates are consistent with your expectations.
On a scale of 0 to 100, Acumen Pharmaceuticals holds a performance score of 2. The firm shows a Beta (market volatility) of 2.0912, which signifies a somewhat significant risk relative to the market. Let's try to break down what Acumen's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Acumen Pharmaceuticals will likely underperform. Although it is vital to follow Acumen Pharmaceuticals historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Acumen Pharmaceuticals technical indicators, you can presently evaluate if the expected return of 0.49% will be sustainable into the future. Please makes use of Acumen Pharmaceuticals variance, value at risk, as well as the relationship between the Value At Risk and skewness to make a quick decision on whether Acumen Pharmaceuticals price patterns will revert.

Auto-correlation

    
  0.29  

Poor predictability

Acumen Pharmaceuticals has poor predictability. Overlapping area represents the amount of predictability between Acumen Pharmaceuticals time series from 9th of November 2022 to 24th of November 2022 and 24th of November 2022 to 9th of December 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acumen Pharmaceuticals price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Acumen Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.29
Spearman Rank Test0.22
Residual Average0.0
Price Variance0.09

Acumen Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Acumen Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Acumen Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Acumen Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Acumen Pharmaceuticals stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
Share
       Timeline  

Acumen Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Acumen Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Acumen Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Acumen Pharmaceuticals stock over time.
   Current vs Lagged Prices   
Share
       Timeline  

Acumen Pharmaceuticals Lagged Returns

When evaluating Acumen Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Acumen Pharmaceuticals stock have on its future price. Acumen Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Acumen Pharmaceuticals autocorrelation shows the relationship between Acumen Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Acumen Pharmaceuticals.
   Regressed Prices   
Share
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acumen Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acumen Pharmaceuticals' short interest history, or implied volatility extrapolated from Acumen Pharmaceuticals options trading.

Pair Trading with Acumen Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acumen Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Acumen Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acumen Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acumen Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acumen Pharmaceuticals to buy it.
The correlation of Acumen Pharmaceuticals is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acumen Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acumen Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acumen Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Acumen Pharmaceuticals Correlation, Acumen Pharmaceuticals Volatility and Acumen Pharmaceuticals Alpha and Beta module to complement your research on Acumen Pharmaceuticals. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Acumen Pharmaceuticals price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Acumen Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Acumen Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Acumen Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...